Data Management Support for Cancer Epidemiology and Genetics
Data Management Support for Cancer Epidemiology and Genetics
批准号:
8948249
负责人:
金额:
$370.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-29 至 2015-09-28
关键词:
Cancer ControlCharacteristicsChemicalsClinicalCollaborationsCollectionCommunitiesComputer SystemsCongressesContractorDataData AnalysesDevelopmentDiseaseDivision of Cancer Epidemiology and GeneticsDocumentationEnvironmental Risk FactorEpidemiologyExposure toExtramural ActivitiesFamilyGeneticGenetic ResearchImageIndividualInfectious AgentInternetIntranetLaboratoriesMaintenanceMalignant NeoplasmsManualsMeasuresMethodsModelingMolecularMolecular EpidemiologyMultinational PerspectivesNational Cancer InstituteOnline SystemsPopulationProcessPublic HealthRadiationResearchResearch DesignResearch InfrastructureResourcesRisk FactorsSecureSiteSourceStatistical ComputingStatistical MethodsSystemSystems AnalysisTechniquesTechnologyTestingUnited States Dept. of Health and Human ServicesUnited States National Institutes of Healthbasecancer epidemiologycancer geneticscancer preventiondata exchangedata managementdesigngene environment interactiongenetic variantinnovationlifestyle factorsnovel strategiesprogramsrepositoryresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Division of Cancer Epidemiology and Genetics (DCEG) conducts population-, family- and laboratory-based research to discover the molecular and environmental etiologic determinants of cancer and new approaches to cancer prevention. The research includes discovering genetic causes of disease and gene-environment interactions by studying the relationship of the putative causal risk factors and genetic variants to phenotypic characteristics (e.g., laboratory measures, imaging findings). The impact of environmental risk factors such as lifestyle factors, exposure to chemicals, infectious agents, and radiation are studied in the context of individuals’ genetic makeup to inform the development of targeted strategies for cancer prevention and control. DCEG’s research strategy is aimed at not only utilizing existing analysis techniques and study designs but also at devising and implementing innovative study designs and analysis methods to leverage emerging biomedical, statistical and computing technologies. The Division maintains a national and international perspective, giving priority to emergent issues identified through clinical, laboratory, and epidemiologic observations. It responds to public health concerns identified by the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Congress, regulatory agencies, and other appropriate bodies. DCEG has developed infrastructures (e.g., molecular laboratories, computing facilities), resources (e.g., repository for biospecimen collections), and strategic partnerships in classical (i.e., not involving biospecimen analyses) and molecular epidemiology and familial genetics across NCI, NIH, and the extramural research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金